Geneva, March 20 -- International Clinical Trials Registry received information related to the study (NCT07449403) titled 'SII Levels Following PENG Block in Hip Arthroplasty' on Feb. 27.

Study Type: Interventional

Study Design: Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).

Primary Sponsor: Poznan University of Medical Sciences

Condition: Hip Osteoarthritis

Intervention: Drug: sodium Chloride

Recruitment Status: Not recruiting

Phase: N/A

Date of First Enrollment: April 1, 2026

Target Sample Size: 60

To know more, visit https://clinicaltrials.gov/study/NCT07449403

Published by HT Digital Content...